Cannaderno
by PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA
· Medical
· Free
No longer on the App Store
Cannaderno is made and published by PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA. AppBrain is an independent app data site and isn't affiliated with PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA. The app name, icon, screenshots and description belong to PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA and are shown as published on the App Store.
AppBrain's verdict
- Last updated
- May 15, 2025
Releases
Updates seen on the App Store- Version
- 2.0.0
- Launched
- November 2022
No changelog data
User feedback
Ratings and reviews on the App StoreComments on Cannaderno for iOS
We don't have enough comments to show example comments. Please check back later.
Technology
Found in the app by AppBrain- Price
- Free
- App size
- 89.6 MB
- Content rating
- High
Technologies used by Cannaderno
About the app and developer
About Cannaderno
Cannaderno was a medical app developed by PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA. It was removed from the App Store Jan 21, 2026.
User Ratings
The app had no ratings.
App Information
Cannaderno was free. The app size was 89.55 MB. The last available version was 2.0.0. The last update was on May 15, 2025.
Technical Requirements
The app had a content rating of High Maturity. The app had been available on the App Store since November 2022.
Developer information for PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA
Store listing
By PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA, from the App StoreThis app is currently not available on the App Store.
Similar apps
Description by PLANTANDO CONHECIMENTO DESENVOLVIMENTO PROFISSIONAL LTDA Written by the developer, not by AppBrain. Click to read.
PT-BR: O principal objetivo do Cannaderno é auxiliar o profissional da área médica, pacientes e/ou seus tutores no acompanhamento do tratamento de saúde com uso terapêutico de remédio a base de Cannabis sativa L, possibilitando-lhes a criação de um diário personalizado com anotações essenciais que possibilitarão atingir a eficácia da medicação prescrita, bem como o uso das informações inseridas para fins de pesquisa científica. Desta forma, buscamos apenas facilitar o registro do tratamento, proporcionando um meio prático e eficaz para monitoramento do tratamento médico, almejando o restabelecimento da saúde do paciente (seja pet ou humano), e contribuindo também com a comunidade médica.
O tratamento canabinóide é aprovado no Brasil pela Diretoria Colegiada da Anvisa, discriminado na lista A3 da Portaria SVS/MS nº 344/98.
“7) fica permitida, excepcionalmente, a importação de produtos que possuam as substâncias canabidiol e/ou tetrahidrocannabinol (THC), quando realizada por pessoa física, para uso próprio, para tratamento de saúde, mediante prescrição médica,[...]”. Para ler mais sobre acesse o site do ministério da saúde em: https://bvsms.saude.gov.br/bvs/saudelegis/svs/1998/prt0344_12_05_1998_rep.html
Diretoria Técnica: Dra. Caroline Helena da Silva Campagnone CRMV/SP 39.770 e Dra. Anna Carolina Golçalves Tames Zambrana CRM/SP 197.219.
O uso deste aplicativo não substitui o acompanhamento médico especializado. Recomendamos que consulte seu médico de confiança.
EN: The main objective of Cannaderno is to help medical professionals, patients and/or their tutors in the monitoring of health treatment with therapeutic use of Cannabis sativa L-based medicine, allowing them to create a personalized diary with essential notes that will make it possible to achieve the effectiveness of the prescribed medication, as well as the use of the information entered for scientific research purposes. In this way, we only seek to facilitate the registration of the treatment, providing a practical and effective way to monitor the medical treatment, aiming at the restoration of the patient's health (whether pet or human), and also contributing to the medical community.
Cannabinoid treatment is approved in Brazil by the Collegiate Board of Anvisa, listed on the A3 list of Ordinance SVS/MS nº 344/98.
“7) the importation of products containing the substances cannabidiol and/or tetrahydrocannabinol (THC) is permitted, when carried out by an individual, for their own use, for health treatment, upon medical prescription, [...]” . To read more about it, visit the Ministry of Health website at: https://bvsms.saude.gov.br/bvs/saudelegis/svs/1998/prt0344_12_05_1998_rep.html
Technical Director: Dr. Caroline Helena da Silva Campagnone CRMV/SP 39.770 and Dr. Anna Carolina Golçalves Tames Zambrana CRM/SP 197.219.
The use of this application does not replace specialized medical monitoring. We recommend that you consult your trusted doctor.
O tratamento canabinóide é aprovado no Brasil pela Diretoria Colegiada da Anvisa, discriminado na lista A3 da Portaria SVS/MS nº 344/98.
“7) fica permitida, excepcionalmente, a importação de produtos que possuam as substâncias canabidiol e/ou tetrahidrocannabinol (THC), quando realizada por pessoa física, para uso próprio, para tratamento de saúde, mediante prescrição médica,[...]”. Para ler mais sobre acesse o site do ministério da saúde em: https://bvsms.saude.gov.br/bvs/saudelegis/svs/1998/prt0344_12_05_1998_rep.html
Diretoria Técnica: Dra. Caroline Helena da Silva Campagnone CRMV/SP 39.770 e Dra. Anna Carolina Golçalves Tames Zambrana CRM/SP 197.219.
O uso deste aplicativo não substitui o acompanhamento médico especializado. Recomendamos que consulte seu médico de confiança.
EN: The main objective of Cannaderno is to help medical professionals, patients and/or their tutors in the monitoring of health treatment with therapeutic use of Cannabis sativa L-based medicine, allowing them to create a personalized diary with essential notes that will make it possible to achieve the effectiveness of the prescribed medication, as well as the use of the information entered for scientific research purposes. In this way, we only seek to facilitate the registration of the treatment, providing a practical and effective way to monitor the medical treatment, aiming at the restoration of the patient's health (whether pet or human), and also contributing to the medical community.
Cannabinoid treatment is approved in Brazil by the Collegiate Board of Anvisa, listed on the A3 list of Ordinance SVS/MS nº 344/98.
“7) the importation of products containing the substances cannabidiol and/or tetrahydrocannabinol (THC) is permitted, when carried out by an individual, for their own use, for health treatment, upon medical prescription, [...]” . To read more about it, visit the Ministry of Health website at: https://bvsms.saude.gov.br/bvs/saudelegis/svs/1998/prt0344_12_05_1998_rep.html
Technical Director: Dr. Caroline Helena da Silva Campagnone CRMV/SP 39.770 and Dr. Anna Carolina Golçalves Tames Zambrana CRM/SP 197.219.
The use of this application does not replace specialized medical monitoring. We recommend that you consult your trusted doctor.